Why the study?
Do anti-thrombotics improve survival and inhibit tumor growth and metastasis in cancer patients?
Population
Cancer patients with a hypercoagulable state or recurrent thrombosis
Design
Review
Authors
Loading...
Hypothesis-generating for anti-tumor effects of LMWH and warfarin in cancer; prospective trials needed before any practice change.
Do anti-thrombotics improve survival and inhibit tumor growth and metastasis in cancer patients?
Anti-thrombotic agents like LMWH and warfarin may have therapeutic potential beyond anticoagulation by inhibiting angiogenesis and tumor metastasis in cancer patients.
Shaker A. Mousa (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: